Integrated traditional and Western medicine for treatment of depression based on syndrome differentiation: a meta-analysis of randomized controlled trials based on the Hamilton depression scale  by KOU, Mei-jing & CHEN, Jia-xu
JTCM |www. journaltcm. com March 15, 2012 | volume 32 | Issue 1 |
Online Submissions: http://www.journaltcm.com J Traditional Chinese Medicine 2012 March 15; 32(1): 1-5
info@journaltcm.com ISSN 0255-2922
© 2012 JTCM. All rights reserved.
Evidence-based Study
KOU Mei-jing, CHEN Jia-xu, School of Pre-clinical Medi-
cine, Beijing University of Chinese Medicine, Beijing 100029,
China; Hubei University of Chinese Medicine, Hubei 430061,
China
Correspondence to: CHEN Jia-Xu, School of Pre-clinical
Medicine, Beijing University of Chinese Medicine, Chaoyang
District, Beijing 100029, PChina. chenjx@bucm.edu.cn
Telephone: +86-10-64286656
Accepted: July 15, 2011
Abstract
OBJECTIVE: To systematically review the benefits
of integrated traditional and Western medicine
therapies based on the Hamilton depression scale
(HAMD) following syndrome differentiation of de-
pression.
METHODS: We searched six English and Chinese
electronic databases for randomized clinical trials
(RCTs) on integrated traditional and Western medi-
cine for treatment of depression. Two authors ex-
tracted data and independently assessed the trial
quality. RevMan 5 software was used for data analy-
ses with an effect estimate presented as weighted
mean difference (WMD) with a 95% confidence in-
terval (CI).
RESULTS: Seven RCTs with 576 participants were
identified for this review. All trials were eligible for
the meta-analysis and were evaluated as unclear or
having a risk of bias. Meta-analysis showed, com-
pared with Western medicine alone, integrated tra-
ditional and Western medicine based on syndrome
differentiation could improve the effect of treat-
ment represented by the HAMD [WMD=-2.39, CI
(-2.96,-1.83), Z=8.29, P<0.00001]. There were no re-
ported serious adverse effects that were related to
integrated traditional and Western medicine based
therapies in these trials.
CONCLUSIONS: Integrated traditional and Western
medicine based therapies for the syndrome differ-
entiation of depression significantly improved the
HAMD, illustrating that combining therapies from
integrated traditional and Western medicine for
treatment of depression is better than Western
medicine alone. However, further large, rigorously
designed trials are warranted due to the insuffi-
cient methodological rigor seen in the trials includ-
ed in this study.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Depression is a form of mood disorder, where sufferers
experience psychological and somatic symptoms[1]. Inci-
dence of depression has significantly increased in re-
cent years, becoming a direct threat to the health of the
young and elderly. Currently, drug therapy is the main
treatment of this disease. The efficacy of these drugs
has been proven, but drug dependence and side effects
are a real risk when using these medications.
In traditional Chinese medicine (TCM), depression is
categorized as depressive psychosis or depressive dis-
ease. Currently, TCM combined with Western medi-
cine has been widely used as a treatment of depression
in China. Thousands of clinical studies, ranging from
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case reports and case series, to controlled and random-
ized trials, have reported the effectiveness of TCM for
depression, but the conclusions from these trials are
not consistent. Limited sample size is one of the main
causes behind this ambiguity. The present meta-analy-
sis of randomized controlled trials using the Hamilton
depression scale (HAMD) as a measure of outcome,
aims to evaluate the evidence for the effectiveness of us-
ing integrated traditional and Western based medicine
on syndrome differentiation for the treatment of de-
pression.
METHODS
Search strategy
Literature searches were conducted on the China Na-
tional Knowledge Infrastructure (1999– 2010), the
VIP Database for Chinese Technical Periodicals (1999
–2010), the Chinese Biomedical Literature Database
(1999–2010), PubMed (1999–2010), Embase (from
its inception until 2009), and the Cochrane Library (Is-
sue 3, 2009). The reference lists in the retrieved papers
were then browsed. All searches were accomplished by
the end of March 2010. Search terms including "de-
pression", "TCM", "Integrated traditional and Western
medicine", "TCM combined with Western medicine",
"syndrome differentiation", and "clinical trial" were
used in various combinations, depending on the data-
base searched. The bibliographies of included trials
were searched for additional references.
Inclusion criteria
We included randomized clinical trials (RCTs) compar-
ing integrated traditional and Western medicine versus
Western medicine alone. All selected trials chose treat-
ment based on syndrome differentiation. RCTs were
the only study design chosen to minimize any poten-
tial bias where nonobjective or patient-reported out-
comes were used. When more than one publication de-
scribed a single study, we extracted data from the one
providing the most detailed information. Non-RCT tri-
als were excluded.
Assessment of methodological quality
The methodological quality of trials was assessed by ex-
amining: the generation of allocation sequence; the al-
location concealment; baseline characteristics; blind-
ing; and withdrawals/dropouts. Based on the "Risk of
Bias" assessment tool on the Cochrane Handbook for
Systematic Reviews of Interventions[2], quality of the in-
cluded trials was categorized as "low risk of bias",
"high risk of bias", and "uncertain risk of bias".
Data extraction
The following study characteristics were tabulated
from the trials: design, participants and diagnosis, inter-
vention and comparator, and clinical outcomes.
Statistical analyses
The statistical package, RevMan 4.3.2, which was pro-
vided by the Cochrane Collaboration, was used for da-
ta analyses. Due to sufficient similarity between the
studies, data outcomes were measured as weighted
mean difference (WMD), with 95% confidence inter-
val (CI).
RESULTS
Description of included trials
In this review, 612 articles were selected from electron-
ic and manual searches. Only 7 articles met the inclu-
sion criteria[3-9]. All studies were journal articles and
published between 2001-2009. The exclusion criteria
were: 1) repeat clinical trials; 2) non-randomized con-
trolled trial[10,13]; 3) therapy not based on TCM syn-
drome differentiation[11,14,15,17,20]; 4) interventions not
meeting the inclusion criteria; and 5) the HAMD score
not used in the study[12,16].
Test characteristics
Diagnostic criteria: Altogether, 576 cases were included
in this study. Five trials used the Chinese Classification
and Diagnostic Criteria of Mental Disorders Version 3
(CCMD-3) [3,6-9], one trial used the Chinese Classifica-
tion and Diagnostic Criteria of Mental Disorders Ver-
sion 2 (CCMD-2)[5], and one trial failed to identify the
source of diagnostic criteria[4]. After reading this article,
it was found to meet the clinical diagnostic criteria.
Treatment programs: Two groups were included in all
articles, the treatment group and the control group. Pa-
tients in the control groups only received Western med-
ical treatment, while those in the treatment groups re-
ceived treatment from Western medicine and Chinese
herbs which were prescribed following a doctor's indi-
cation of syndrome differentiation. Eleven syndromes
and 12 Chinese herbal decoctions were described in
this study (shown in Table 1).
Outcome indicators: All seven studies used the
HAMD (shown in Table 2).
Methodological quality of included trials
All 7 trials were described as randomized, but only one
trial gave details of the methods used for generating the
allocation sequence (i.e. random number tables). Giv-
en these findings, we evaluated that the randomization
quality in one trial was adequate. The quality of the re-
maining trials was unclear.
All trials reported that baseline characteristics between
the groups were comparable. No trials clearly described
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the method used to generate allocation concealment.
No trials mentioned who was blinded to treatment allo-
cation. Only one trial reported withdrawal/dropout in-
formation. No trial provided information on inten-
tion-to-treat, or prior sample size estimation. Accord-
ingly, the included trials had generally low methodolog-
ical quality (with high risk of bias), and most of the
studies fell into the uncertain risk of bias category
(shown in Table 3).
Meta-analysis of Hamilton Depression Scale scores
The outcome of meta-analysis shows there is significant
difference between treatment group and control group.
WMD=-2.39, CI (-2.96,-1.83), Z=8.29, P<0.00001
(shown in Figure 1).
DISCUSSION
Syndrome differentiation is one of the basic characteris-
tics of TCM theory. Based on syndrome differentia-
tion, a disease may have different types of syndromes.
Therefore, a variety of therapies in TCM may exist, ac-
cording to the patient's condition, for the treatment of
the same disease[12]. In this study, we found 11 syn-
dromes involved in depression, including the syn-
drome of blood stasis due to deficient Qi, the syn-
drome of stagnation of liver Qi and spleen deficiency,
the syndrome of stagnation of liver Qi, the syndrome
of stagnation of liver Qi and endogenous heat due to
yin deficiency, the syndrome of deficiency of both
heart and spleen, the syndrome of disharmony between
heart and kidney, the syndrome of stagnated liver Qi
and disturbing phlegm, the syndrome of Qi depression
transforming into fire, Qi stagnation and blood stasis,
the syndrome of yin deficiency of liver and kidney, and
the syndrome of kidney deficiency and stagnation of
liver Qi. The most common syndrome seen in this
study was the syndrome of stagnation of liver Qi and
spleen.
Table 1 Syndromes and treatments found in the included trials
Included trials
Shaojing3
Lihong4
Jiangyouqian5
Niusuying6
Zhangtao7
Qihaojun8
Liujinpeng9
Treatment group
Decoction benefiting Qi and relieving Qi stagnation with modification for syndrome of
blood stasis due to deficient Qi, combined with Deanxit
Xiaoyao powder for syndrome of stagnation of liver Qi and spleen deficiency,
combined with fluoxetine hydrochloride
Decoction of danzhi xiaoyao for syndrome of stagnation of liver Qi, decoction of
Huanglian Wendan for syndrome of stagnation of liver Qi and endogenous heat due to
yin deficiency, Guipi decoction for syndrome of deficiency of both heart and spleen,
Liuwei dihuang pill and Jiaotai pill for syndrome of disharmony between heart and
kidney, combined with fluoxetine
Chaihu shugan powder for syndrome of stagnated liver Qi and disturbing phlegm,
decoction of Danzhi Xiaoyao for syndrome of Qi depression transforming into fire,
Xuefu zhuyu decoction for syndrome of Qi stagnation and blood stasis, oral liquid of
Zishui Qinggan for syndrome of yin deficiency of liver and kidney, Yueju pill for
syndrome of stagnation of liver Qi and spleen deficiency, combined with paroxetine
Xiaoyao powder for syndrome of stagnation of liver Qi and spleen deficiency, Xiaoyao
powder and Guipi decoction for syndrome of deficiency of both heart and spleen,
Xiaoyao powder and Liuwei Dihuang pill for syndrome of yin deficiency of liver and
kidney, combined with Seroxat
Decoction of Bushen Jieyu for syndrome of kidney deficiency and stagnation of liver Qi,
combined with fluoxetine
Chaihu shugan powder for syndrome of stagnated liver Qi, Xuefu zhuyu decoction for
syndrome of Qi stagnation and blood stasis, Wendan decoction for syndrome of
stagnated liver Qi and disturbing phlegm, Guipi decoction for syndrome of deficiency of
both heart and spleen, combined with venlafaxine
Control group
Deanxit
Fluoxetine hydrochloride
Fluoxetine
Paroxetine
Seroxat
Fluoxetine
Venlafaxine
Table 2 Hamilton depression scale score from included trials
Included trials
Shaojing3
Lihong4
Jiangyouqian5
Niusuying6
Zhangtao7
Treatment group
cases
28
41
30
50
60
Before treatment
28.83±4.96
30.80±3.80
19.50±3.42
37.75±5.51
32.06±6.91
After treatment
17.97±4.07
9.70±1.80
8.90±4.80
13.12±2.14
12.02±5.86
Control group
cases
28
39
30
50
40
Before treatment
28.17±5.13
30.90±3.70
20.37±3.47
36.71±5.59
31.63±7.86
After treatment
18.53±4.13
11.50±2.10
11.90±4.71
16.33±4.37
15.36±6.08
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Qihaojun8
Liujinpeng9
60
30
25.31±6.05
27.06±4.85
10.51±2.35
5.10±9.32
60
30
25.41±5.08
26.35±4.65
13.81±4.49
6.04±8.68
Table 3 Methodological quality of included trials
Included trials
Shaojing3
Lihong4
Jiangyouqian5
Niusuying6
Zhangtao7
Qihaojun8
Liujinpeng9
Treatment
duration(w)
6
6
6
8
6
6
6
outcome
indicator
HAMD
HAMD
HAMD
HAMD
HAMD
HAMD
HAMD
Random
unclear
unclear
unclear
random number tables
unclear
unclear
unclear
Allocation
concealment
unclear
unclear
unclear
unclear
unclear
unclear
unclear
Blind
unclear
unclear
unclear
unclear
unclear
unclear
unclear
Baseline
Consistent
Consistent
Consistent
Consistent
Consistent
Consistent
Consistent
withdrawal
s/dropouts
0
2
0
0
0
0
0
Figure 1 Meta-analysis of Hamilton depression scale scores.
Syndrome of stagnation of liver Qi and spleen deficien-
cy is one of the common syndromes of depression. Ex-
cessive pressure from work or a poor emotional state
will lead to the dysfunction of "liver controlling con-
veyance and dispersion" and the stagnation of liver Qi
will result in spleen and stomach disorders. As a result,
depression, anxiety, fatigue and other symptoms will
occur. Therefore, further research between depression
and stagnation of liver Qi and spleen deficiency should
be conducted.
HAMD is a classic depression rating scale, which is
most commonly used in clinical assessment of depres-
sion. It is also an objective scale to evaluate effective-
ness of treatment. The meta-analysis on data from the
HAMD showed a significant benefit of integrated tra-
ditional and Western medicine based on syndrome dif-
ferentiation in the treatment of depression. Though
the quality of all the included trials is generally low, the
conclusions from a meta-analysis are more comprehen-
sive and reliable than a single trail.
Based on the "risk of bias" assessment tool in the Co-
chrane approach, the quality of most included trials
was categorized as "uncertain risk of bias". Proper ran-
domization techniques need to be used, clearly de-
scribed, and fully reported. An intention-to-treat prin-
ciple and an appropriate method for including drop-
outs in data analyses are also important in the design of
the trials. Considering there are insufficient high-quali-
ty trials on integrated traditional and Western medi-
cine based on syndrome differentiation treatment of de-
pression, proof of the effectiveness of this mode of
treatment will require further rigorous trials. There-
fore, the authors suggest that the efficacy of TCM
should be seriously evaluated according to the princi-
ples of evidence-based medicine and based on syn-
drome differentiation, even though abundant clinical
experience, especially case reports, have been repeated
and treatments have lasted for thousands of years[19-21].
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